Search Results
Found 2 results
510(k) Data Aggregation
(60 days)
FLEXSITE DIAGNOSTICS, INC.
Ask a specific question about this device
(105 days)
FLEXSITE DIAGNOSTICS, INC.
For over-the-counter at home or doctor's office use to obtain a finger stick whole blood sample for laboratory to monitor long-term (4-8 weeks) blood sugar control in individuals with diabetes mellitus. Not indicated for diagnosis of diabetes mellitus.
The device is a kit containing the materials required to collect a capillary blood sample from a finger-stick on a piece of filter paper and mail it to a laboratory for determination of its hemoglobin A16 %. The kit contains a lancet, an alcohol wipe, a test request form with filter paper, a biohazard bag, a return envelope with lifter papereturning a result to the patient and/or his/her doctor.
Here's an analysis of the provided text regarding the EZCHEK™/HbA1c Sample Collection Kit's acceptance criteria and studies:
Acceptance Criteria and Device Performance
The acceptance criteria are implied through correlation coefficients and precision values. The studies demonstrated that the device (specifically, the collection method on filter paper combined with the new antibody-based analytical method) correlates well with existing whole blood hemolysate tests and exhibits acceptable precision.
Metric | Acceptance Criteria (Implied) | Reported Device Performance (Nonclinical) | Reported Device Performance (Clinical - Office) | Reported Device Performance (Clinical - Home) |
---|---|---|---|---|
Correlation (r) | High (e.g., >0.95) | 0.988 | 0.978 | 0.956 |
Equation (y=mx+c) | Close to y=x | y = 1.03x - 0.13 | Y = 0.999x + 0.06 | y = 0.983x + 0.37 |
Within-run Precision | Not explicitly stated | 2.9% at 6.7% HbA1c | Not reported | Not reported |
Total Precision | Not explicitly stated | 3.3% at 6.7% HbA1c | Not reported | Not reported |
Stability (temperature) | Compatible with transport | Shown to be compatible | Not reported | Not reported |
Stability (freeze-thaw) | Compatible with transport | Shown to be compatible | Not reported | Not reported |
Ease of Use (User Feedback) | Acceptable | Not reported | Acceptable (indicated by questionnaires) | Acceptable (indicated by questionnaires) |
Study Details
-
Sample Sizes and Data Provenance:
- Nonclinical Performance Data (Correlation): n = 53 (data provenance not specified, but this would likely be laboratory-based testing)
- Clinical Performance Data (Office Use): n = 56 (data provenance not specified, but implied to be from three clinical sites)
- Clinical Performance Data (Home Use): n = 43 (data provenance not specified, but implied to be from patients collecting samples at home)
- Retrospective/Prospective: Not explicitly stated, but the "clinical performance data" sounds prospective given the evaluation of kits in sites and patient questionnaires. The "nonclinical performance data" could be either.
-
Number of Experts and Qualifications for Test Set Ground Truth:
- The document does not mention the number of experts or their qualifications for establishing the ground truth for the test set. The ground truth refers to "whole blood hemolysate tests," which are a reference method, not expert-derived.
-
Adjudication Method for the Test Set:
- This is not applicable as the studies primarily involve correlation comparisons against a reference laboratory method (whole blood hemolysate tests), not subjective expert judgment requiring adjudication.
-
Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
- No, a MRMC comparative effectiveness study was not done. This type of study is typically used for imaging or diagnostic tools where human readers interpret results, and the AI's impact on their performance is evaluated. The EZCHEK™ kit is a sample collection device for a laboratory test, not an interpretive tool for human readers.
-
Standalone (Algorithm Only) Performance:
- Yes, the performance presented for the device is essentially standalone. The "device" here is the collection kit, and its performance is evaluated in terms of how well the collected sample yields results that correlate with a reference method. The "new antibody based method" which processes the collected samples is itself FDA cleared and operates in a standalone manner.
-
Type of Ground Truth Used:
- The ground truth used was "whole blood hemolysate tests." This is a laboratory reference method for HbA1c determination, considered the gold standard for comparison in these studies.
-
Sample Size for the Training Set:
- The document does not provide information about a "training set" or its size. This is because the device described is a sample collection kit and the new analytical method it uses is already FDA cleared. The studies presented are validation studies of the combined system (collection method + new analytical method), not a new AI algorithm that requires training.
-
How Ground Truth for the Training Set Was Established:
- Not applicable, as no training set for an AI algorithm is mentioned or implied.
Ask a specific question about this device
Page 1 of 1